ARS Pharmaceuticals SPRY
NASDAQ SPRY
$4.29 -0.02 (-0.46%)
As of: Oct 1, 2026 · 10:48 AM EDT

ARS Pharmaceuticals (SPRY) Preferred Stock Liabilities (2021)

Updated

ARS Pharmaceuticals' Preferred Stock Liabilities came in at $76.04 million for Q4 2021.

Analysis

ARS Pharmaceuticals (SPRY) Preferred Stock Liabilities (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 ARS Pharmaceuticals 428.58 Mn 284.78 Mn 20.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 76.04 Mn
API Access

ARS Pharmaceuticals Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=SPRY&period=max&api_key=YOUR_API_KEY